BY MARIUS AMBAKK BJORKEDAL
-
Be Wary of Bluesky
Remarks …Read More
-
Zendesk spam wave returns, floods users with ‘Activate account’ emails
A fresh wave of spam is striking inboxes worldwide, with individuals reporting that they are once more being pounded by automatic e-mails produced via business’ unsafe Zendes…
-
Pharma industry’s biggest acquisition in two years could collapse
MSD is no more in talks with cancer cells medication designer Transformation Medicines.
-
Sanofi acquires vaccine company for over USD 2 billion
The billion-dollar purchase will certainly aid broaden the Sanofi’s profile of vaccinations for grownups.
-
Sanofi acquires Alzheimer’s candidate for over USD 1 billion
Sanofi protects legal rights to Alzheimer’s prospect from South Korea’s Adel.
-
Ambu recruits Nordic sales director from Karl Storz in Norway
The previous Norwegian head of endoscopy at Karl Storz signs up with Ambu to lead the firm’s company options effort in the Nordic area.
-
Top US advisor: How China took control of Western medicine production
Wellness economic expert Marta E. Wosińska thinks that Western medical care systems will certainly get on unstable ground if China cuts off products. Norway shares the worry regard…
-
Sanofi completes acquisition of British company
The procurement of British business Vicebio requires information innovation in the area of vaccinations for the French pharmaceutical business.
-
Sanofi completes acquisition of British company
The acquisition of British company Vicebio entails news technology in the field of vaccines for the French pharmaceutical company.
-
Industry leader: The US could lose its biotech leadership to China within two years
The US risks losing its global leadership position in biotechnology to China within the next two to three years, according to BIO leader John Crowley.
